The People's Insurance Company (Group) of China Limited (601319.SS)
Beijing, CN
Operating as an investment holding entity, The People's Insurance Company (Group) of China Limited primarily conducts insurance operations throughout the People's Republic of China. Its operations are structured across Non-Life, Life, and Health Insurance segments, in addition to Asset Management and other auxiliary divisions. The firm provides a comprehensive spectrum of property and casualty coverage, encompassing motor vehicle, commercial property, liability, credit, personal accident and health, cargo, and agricultural insurance, among various other offerings. Furthermore, its life insurance portfolio includes general life and health, participating life, universal life, and accident policies. Its specialized health insurance offerings span medical, illness, nursing care, accidental injury, disability loss, and participating endowment policies. Beyond these core insurance activities, the company is also involved in asset management, functions as an insurance agent, participates in reinsurance, and delivers integrated financial solutions. Established in 1949, this enterprise maintains its headquarters in Beijing, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.33% | -1.44% | -4.74% | -20.19% | -21.02% | -23.58% | -17.29% | +10.86% | +11.04% | +42.20% | +42.20% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Property & Casualty: +14.1%+9.5% Q1'26: +21.8% (vs Q1'25)
-
EPS growth Insurance - Property & Casualty: +27.5%+9.2% Q1'26: -31.0% (vs Q1'25)
-
FCF margin FCF growth · Insurance - Property & Casualty: +25.6%+30.5% ★ Q1'26: +12.9% (vs Q1'25)
-
EBIT margin Insurance - Property & Casualty: +16.3%+11.9% Q1'26: +7.6% (vs Q1'25)
-
ROIC Insurance - Property & Casualty: +7.9%+10.9% ★ Q1'26: +8.6% (vs Q1'25)
-
Share dilution Insurance - Property & Casualty: +0.4%-0.4% ★ Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Property & Casualty: -0.10×2.71× Q1'26: 3.87× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 5 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 1 Rev. Ana. 9 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
404.97B
est: 340.34B (+19.0%)
|
442.32B
est: 393.40B (+12.4%)
|
481.78B
est: 429.79B (+12.1%)
|
497.16B
est: 452.09B (+10.0%)
|
549.91B
est: 500.43B (+9.9%)
|
579.07B
est: 553.88B (+4.5%)
|
592.02B
est: 546.85B (+8.3%)
|
475.09B
est: 568.02B (-16.4%)
|
530.21B
est: 576.07B (-8.0%)
|
598.79B
est: 581.48B (+3.0%)
|
655.91B
est: 669.25B (-2.0%)
|
664.20B
636.73B – 695.14B
-0.8% YoY
|
698.27B
639.15B – 764.89B
+5.1% YoY
|
743.28B
712.54B – 777.91B
+6.4% YoY
|
| EBITDA |
41.01B
est: 31.97B (+28.3%)
|
31.94B
est: 36.95B (-13.6%)
|
38.66B
est: 40.37B (-4.2%)
|
36.26B
est: 42.46B (-14.6%)
|
39.05B
est: 47.00B (-16.9%)
|
41.75B
est: 52.02B (-19.8%)
|
45.90B
est: 51.36B (-10.6%)
|
52.85B
est: 53.35B (-0.9%)
|
42.07B
est: 54.11B (-22.2%)
|
77.48B
est: 60.93B (+27.2%)
|
82.91B
est: 70.13B (+18.2%)
|
69.60B
66.72B – 72.84B
-0.8% YoY
|
73.17B
66.97B – 80.15B
+5.1% YoY
|
77.89B
74.67B – 81.52B
+6.4% YoY
|
| EBIT |
38.57B
est: 28.93B (+33.3%)
|
29.65B
est: 33.44B (-11.3%)
|
36.40B
est: 36.54B (-0.4%)
|
33.61B
est: 38.43B (-12.5%)
|
34.95B
est: 42.54B (-17.8%)
|
37.30B
est: 47.09B (-20.8%)
|
41.14B
est: 46.49B (-11.5%)
|
47.66B
est: 48.29B (-1.3%)
|
37.02B
est: 48.97B (-24.4%)
|
72.48B
est: 55.74B (+30.0%)
|
77.81B
est: 64.15B (+21.3%)
|
63.67B
61.03B – 66.63B
-0.8% YoY
|
66.93B
61.27B – 73.32B
+5.1% YoY
|
71.25B
68.30B – 74.57B
+6.4% YoY
|
| Net Income |
19.54B
est: 18.61B (+5.0%)
|
14.25B
est: 13.75B (+3.6%)
|
16.10B
est: 18.13B (-11.2%)
|
12.91B
est: 15.19B (-15.0%)
|
22.14B
est: 22.74B (-2.7%)
|
20.04B
est: 20.34B (-1.5%)
|
21.48B
est: 22.43B (-4.3%)
|
25.37B
est: 24.82B (+2.2%)
|
22.32B
est: 23.03B (-3.1%)
|
42.15B
est: 40.52B (+4.0%)
|
46.65B
est: 44.22B (+5.5%)
|
46.04B
43.57B – 48.83B
+4.1% YoY
|
49.77B
47.09B – 52.78B
+8.1% YoY
|
53.09B
50.24B – 56.31B
+6.7% YoY
|
| SGA |
24.61B
est: 15.83B (+55.4%)
|
27.85B
est: 18.30B (+52.2%)
|
31.10B
est: 19.99B (+55.5%)
|
14.48B
est: 21.03B (-31.1%)
|
28.27B
est: 23.28B (+21.4%)
|
38.49B
est: 25.77B (+49.4%)
|
18.60B
est: 25.44B (-26.9%)
|
23.72B
est: 26.42B (-10.2%)
|
27.12B
est: 26.80B (+1.2%)
|
20.14B
est: 19.32B (+4.2%)
|
—
est: 22.24B (-100.0%)
|
22.07B
21.16B – 23.10B
-0.8% YoY
|
23.20B
21.24B – 25.41B
+5.1% YoY
|
24.70B
23.68B – 25.85B
+6.4% YoY
|
| EPS |
0.46
est: 0.42 (+9.8%)
|
0.34
est: 0.31 (+9.8%)
|
0.38
est: 0.41 (-6.9%)
|
0.30
est: 0.34 (-12.3%)
|
0.50
est: 0.51 (-2.4%)
|
0.45
est: 0.46 (-1.0%)
|
0.49
est: 0.51 (-3.0%)
|
0.57
est: 0.56 (+2.6%)
|
0.50
est: 0.52 (-3.6%)
|
0.95
est: 0.92 (+3.7%)
|
1.05
est: 1.00 (+5.0%)
|
1.04
0.99 – 1.10
+4.1% YoY
|
1.13
1.06 – 1.19
+8.1% YoY
|
1.20
1.14 – 1.27
+6.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 2/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 4/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Shangyou Zeng | Secretary of the Board | 1M | male |
| Houjie Zhou | Chief Financial Officer & Financial Controller | 1M | male |
| Xiangqun Ding | Executive Chairperson | 1M | female |
| Peng Zhao | Vice Chairman & President | 1M | male |
| Jianyou Xiao | Vice President & Executive Director | 930.0K | male |
| Zhiwei Cai | Vice President | 912.8K | male |
| Jinhai Zhang | Vice President & Senior Engineer | 912.8K | male |
| Ze Yu | Vice President | 912.8K | male |
| Geng Tian | Vice President | 912.8K | male |
| Qing feng Shi | Head of the Discipline Inspection & Supervision Team of the People's Insurance Group | 256.3K | male |
| Ruikai Zhang | Deputy Secretary General | — | — |
| Sau Mei Ng ACIS FCIS | Company Secretary | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 601319.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
